Press Releases

Investors Menu

Episurf Medical enters into a letter of intent regarding the acquisition of a property portfolio with an agreed property value of approximately SEK 505 mn

Episurf Medical AB (publ) (“Episurf” or the “Company”) has today entered into a letter of intent regarding the acquisition of all shares in five property-owning companies. The agreed underlying property value amounts to approximately SEK 505 mn before deduction for deferred tax. The parties’ objective is to enter into a final share purchase agreement no later than 30 September 2026, with completion planned for around 1 November 2026. The portfolio consists of five modern, newly…

Episurf Medical has entered into an agreement for the financing of the Lilium and Setune acquisitions and closing of the property acquisitions takes place on 31 August 2026

Episurf Medical AB (publ) ("Episurf" or the "Company") (Nasdaq Stockholm: EPIS B) has entered into an agreement for the financing of the previously communicated acquisitions of the property portfolio comprising 45 properties from Fastighetsaktiebolaget Lilium (the "Lilium Acquisition") and the property portfolio comprising four properties from Setune Assets AB (the "Setune Acquisition", and together with the Lilium Acquisition, the "Acquisitions"). The closing of the Acquisitions will take place on 31 August 2026. "We are pleased…

Change in number of shares and votes in Episurf Medical

As a result of, in accordance with previously announced information, the directed issue of 2,888,888,888 Class B shares resolved on 3 July 2026 as well as the directed issue of an additional number of 868,702,560 Class B shares resolved on 8 July 2026, the number of shares and votes in Episurf Medical AB (publ) (“Episurf”) has changed. Through the above-mentioned changes, the total number of shares in Episurf as of 31 July 2026 amounts to…

    The Board of Directors of Episurf has resolved on an issue of Class B shares as part of partial closing

    NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF…

      Episurf Medical completes the first partial closing of the portfolio announced on 5 June 2026, acquiring properties with an agreed property value of SEK 301 mn

      Episurf Medical AB (publ) (“Episurf” or the “Company”) announced on 5 June 2026 the acquisition of a property portfolio of 30 properties in Södermanland and Östergötland, with an agreed property value of SEK 920 mn. Closing of the portfolio takes place in several parts. The first partial closing is carried out today, 7 July 2026, and comprises properties with an agreed property value of SEK 301 mn. The partial closing in brief The partial closing…

        The Board of Directors of Episurf has resolved on an issue of Class B shares as part of the consideration for the acquisition of property assets

        NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO AUSTRALIA, BELARUS, CANADA, HONG KONG, ISRAEL, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, THE UNITED KINGDOM, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR DISCLOSURE WOULD BE IN VIOLATION OF APPLICABLE LAWS OR REQUIRE ADDITIONAL REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO THE SECTION "IMPORTANT INFORMATION" AT THE END OF…

        Correction: Change in number of shares and votes in Episurf Medical

        Corrected information The correct number of Class B shares is 6,930,364,588, previously incorrectly stated as 6,929,891,231. The correct total number of votes is 6,931,784,659, previously incorrectly stated as 6,931,311,302. The total number of shares (6,930,837,945) and the number of Class A shares (473,357) were stated correctly and are unchanged. In full, the information shall read: As a result of, in accordance with previously announced information, the directed issue of 1,711,111,111 Class B shares resolved on…

          Change in number of shares and votes in Episurf Medical

          Through the above-mentioned changes, the total number of shares in Episurf amounts to 6,930,837,945, of which 473,357 are Class A shares and 6,929,891,231 are Class B shares, and the total number of votes in Episurf amounts to 6,931,311,302. For further information, please contact: Jens Andersson, CEO, Episurf Medical Tel: +46(0) 768 55 67 02 Email jens.andersson@episurf.com This information is information that Episurf Medical AB (publ) is obliged to make public pursuant to the Financial Instruments…

            Episurf Medical has entered into a financing agreement for the KlaraBo acquisition and closing of the property portfolio takes place on 2 July 2026

            Closing Closing of the entire property portfolio takes place on 2 July 2026. The financial closing takes effect as of 30 June 2026. For one of the properties, corresponding to an agreed property value of approximately SEK 233 mn, legal closing will take place no later than 18 months after the closing date. The reason for the deferred legal closing is that the property in question has a relatively large vacancy. Until legal closing, Episurf…

            Subscribe to our Investor updates